AU3799997A - Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity - Google Patents
Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivityInfo
- Publication number
- AU3799997A AU3799997A AU37999/97A AU3799997A AU3799997A AU 3799997 A AU3799997 A AU 3799997A AU 37999/97 A AU37999/97 A AU 37999/97A AU 3799997 A AU3799997 A AU 3799997A AU 3799997 A AU3799997 A AU 3799997A
- Authority
- AU
- Australia
- Prior art keywords
- desethyloxybutynin
- oxybutynin
- treatment
- dextrorotatory isomers
- gastrointestinal hyperactivity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2140296P | 1996-07-09 | 1996-07-09 | |
US60021402 | 1996-07-09 | ||
PCT/US1997/012284 WO1998001125A2 (en) | 1996-07-09 | 1997-07-09 | Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3799997A true AU3799997A (en) | 1998-02-02 |
Family
ID=21804010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU37999/97A Abandoned AU3799997A (en) | 1996-07-09 | 1997-07-09 | Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3799997A (en) |
WO (1) | WO1998001125A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000071108A2 (en) * | 1999-05-20 | 2000-11-30 | Sepracor Inc. | Methods for treatment of asthma using s-oxybutynin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL124473C (en) * | 1960-07-26 | |||
AU7994694A (en) * | 1994-10-21 | 1996-05-15 | Leiras Oy | Controlled release oral delivery system containing oxybutynin |
-
1997
- 1997-07-09 WO PCT/US1997/012284 patent/WO1998001125A2/en active Application Filing
- 1997-07-09 AU AU37999/97A patent/AU3799997A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998001125A3 (en) | 1998-05-07 |
WO1998001125A2 (en) | 1998-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3102297A (en) | Under water treatment | |
AU3725997A (en) | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders | |
AU5687896A (en) | Use of alpha 1L-agonists in the treatment of incontinence | |
AU2113295A (en) | Novel compositions and methods for water treatment | |
AU3441197A (en) | 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes | |
AU5981098A (en) | Therapeutic gestagens for the treatment of premenstrual dysphoric disorder | |
IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
AU7384094A (en) | Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders | |
AU3745895A (en) | Use of gaba antagonists in the treatment of emesis | |
AU2418499A (en) | Org-5222 in the treatment of depression | |
AU5056099A (en) | Compounds for use in the treatment of inflammation | |
HK1022267A1 (en) | Use of 1-hydroxy-2-pyridones for the treatment of saborrheic dermatitis | |
AU2160697A (en) | Nsaids in the treatment of pruritus | |
AU2870597A (en) | Treatment of liquid | |
AU2801595A (en) | Water treatment | |
ZA973843B (en) | Treatment of asthma with TNFR-lg. | |
AU2052697A (en) | Macrocyclic peptides useful in the treatment of thrombin related disorders | |
AU1853397A (en) | Treatment of pulmonary inflammation | |
AU5446798A (en) | Compositions and methods for the treatment of gastrointestinal disorders | |
HUP9902802A3 (en) | Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders | |
AU3799997A (en) | Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity | |
AU2573197A (en) | Water treatment | |
GB9726223D0 (en) | The treatment of materials | |
AU1587295A (en) | The treatment of gaseous substances | |
AU2713797A (en) | Depigmentating agent in the treatment of melasma |